Michael Mussallem - Edwards Lifesciences Insider

Edwards Lifesciences Corporation -- USA Stock  

USD 117.1  1.08  0.91%

Chairman and CEO

Mr. Michael A. Mussallem is Chairman of the Board, Chief Executive Officer of the Company. He has an extensive knowledge of the medical technology industry in general, and of the people, operations, processes and products of the Company, in particular, built over a 35year career with the Company and its predecessor. In addition, in his roles with AdvaMed and other healthcarerelated organizations, he has become a recognized leader in the medical technology industry, making important contributions to healthcare policy discussions in California, the United States and the key global markets that the Company serves. These experiences have established relationships which are helpful in developing the Board strategic perspective and enhanced his leadership of the Company and contributions to the Board. He received his BS in Chemical Engineering and an honorary doctoral degree from the Rose Hulman Institute of Technology
Age: 63  Chairman Since 2000  Ph.D    
949 250-2500  www.edwards.com

Michael Mussallem Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 12.64 % which means that for every $100 of asset it generated profit of $12.64. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 25.45 % which means that it produced $25.45 on every 100 dollars invested by current stockholders.
The company reports 1.03 B of total liabilities with total debt to equity ratio (D/E) of 32.7 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 3.42 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Found 6 records

CHAIRMAN Since

Timothy RingC R Bard Inc
2003
George PazExpress Scripts Holding Company
2016
Robert ParkinsonBaxter International Inc
2016
Vincent ForlenzaBecton Dickinson and Company
2017
Richard GozonAmerisourceBergen Corporation
2006
Jose AlmeidaBaxter International Inc
2016

Entity Summary

Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 9,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Crypto Portfolio Optimizer Now
   

Crypto Portfolio Optimizer

Optimize portfolio of digital coins and token across multiple currency and exchanges
Hide  View All  NextLaunch Crypto Portfolio Optimizer
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Edwards Lifesciences Corporation to your portfolio

Top Management

Edwards Lifesciences Leadership Team
John Cardis, Director
Wesley Schack, Director, MBA
Larry Wood, VP, MBA
Nicholas Valeriani, Director, MBA
Leslie Heisz, Director, MBA
Catherine Szyman, President, MBA
Martha Marsh, Director, MBA
Huimin Wang, President, MBA
Barbara McNeil, Director, Ph.D
Steven Loranger, Director
William Link, Director
Scott Ullem, CFO, MBA
Patrick Verguet, VP, Ph.D
Kieran Gallahue, Director, MBA
Bernard Zovighian, President, MBA
David Erickson, President
Donald Bobo, VP
Michael Mussallem, Chairman, Ph.D

Stock Performance

Edwards Lifesciences Performance Indicators